Resources

Charts and graphs

Weekly admissions of children with invasive pneumococcal disease at Kilifi County Hospital and vaccination coverage in Kilifi county

Academic journal articles

Flasche S, Ojal J, Le Polain de Waroux O, Otiende M, O'Brien KL, Kiti M, Nokes DJ, Edmunds WJ, Scott JAG (2017) Assessing the efficiency of catch-up campaigns for the introduction of pneumococcal conjugate vaccine: a modelling study based on data from PCV10 introduction in Kilifi, Kenya. BMC Med, 15(1), 113. doi:10.1186/s12916-017-0882-9

Ojal J, Hammitt LL, Gaitho J, Scott JAG, Goldblatt D (2017) Pneumococcal conjugate vaccine induced IgG and nasopharyngeal carriage of pneumococci: Hyporesponsiveness and immune correlates of protection for carriage. Vaccine, 35(35 Pt B), 4652-4657. doi:10.1016/j.vaccine.2017.05.088

Ojal J, Flasche S, Hammitt LL, Akech D, Kiti MC, Kamau T, Adetifa I, Nurhonen M, Scott JAG, Auranen K (2017), Sustained reduction in vaccine-type invasive pneumococcal disease despite waning effects of a catch-up campaign in Kilifi, Kenya: A mathematical model based on pre-vaccination data. Vaccine Aug 16;35(35 Pt B):4561-4568. doi:10.1016/j.vaccine.2017.07.019.

Adetifa I, Bwanaali T, Wafula J, Mutuku A, Karia B, Makumi A, Mwatsuma P, Bauni E, Hammitt L, Nokes DJ (2017) Cohort Profile: The Kilifi Vaccine Monitoring Study, International Journal of Epidemiology, Volume 46, Issue 3, 1 June 2017, Pages 792–792h, doi: 10.1093/ije/dyw202

Conference posters, presentations and sessions

Hammitt LL, Akech D, Morpeth S, Ojal J, Karani A, Odipo E, Ooko M, Voller S, Mataza C, Tabu C, Adetifa I, Scott JAG (2018) Population impact of 10-valent pneumococcal conjugate vaccine (PCV10) on nasopharyngeal carriage disease of Streptococcus Pneumoniae in Kilifi, Kenya. Poster, 11th International Symposium on Pneumococci and Pneumococcal Diseases, 15-19 April, Melbourne, Australia

Scott JAG, Otiende M, Makumi A, Hammitt LL, Adetifa I, Bauni E, Tabu C, Williams TN, (2018) The impact of 10-valent pneumococcal vaccine introduction on all-cause mortality among children in Kilifi, Kenya. Poster and spotlight session, 11th International Symposium on Pneumococci and Pneumococcal Diseases, 15-19 April, Melbourne, Australia

Simiyu S, Karani AM, Karanu A, Ooko M, Koros J, Gardiner E, Waichungo J, Nyongesa S, Odipo E, Waithaka M, Adetifa IMO, Morpeth S, Hammitt LL, Scott JAG (2018) The epidemiology of serogroup 6 streptococcus pneumoniae carriage and invasive disease in Kilifi, Kenya, and effect of the 10-valent pneumococcal conjugate vaccine. Poster, 11th International Symposium on Pneumococci and Pneumococcal Diseases, 15-19 April, Melbourne, Australia

Otiti MI, Akech D, Simiyu S, Karani A, Muthumbi E, Waithaka M, Ojal J, Gordon C, Kariuki S, Hammitt LL, Tabu C, Verani JR, Bigogo G, Scott JAG, Adetifa IMO (2018) Residual nasopharyngeal carriage of vaccine type pneumococci in a mature pcv10 immunisation programme in Kenya. Poster, 11th International Symposium on Pneumococci and Pneumococcal Diseases, 15-19 April, Melbourne, Australia

Otiende M, Karia B, Mutuku A, Bottomley C, Adetifa I, Scott JAG (2018) Sham vaccination with pentavalent vaccine (dpt-hepb-hib) to estimate bias in observational effectiveness studies of pneumococcal conjugate vaccines. Poster and spotlight session, 11th International Symposium on Pneumococci and Pneumococcal Diseases, 15-19 April, Melbourne, Australia

Ojal J (2018) The merits of sustaining pneumococcal vaccination after transitioning from Gavi support – a cost-effectiveness study for Kenya. Oral presentation, 11th International Symposium on Pneumococci and Pneumococcal Diseases, 15-19 April, Melbourne, Australia

Scott A (2016) What have vaccines and different vaccine schedules done to the burden of pneumococcal disease. Plenary talk, 10th International Symposium on Pneumococci and Pneumococcal Diseases, 26-30 June, Glasgow, Scotland

Hammitt L (2016) Using carriage to measure vaccine impact and Population impact of PCV on pneumococcal carriage in Kilifi, Kenya. Meet the expert session, 10th International Symposium on Pneumococci and Pneumococcal Diseases, 26-30 June, Glasgow, Scotland

Ojal J (2016) Cost effectiveness of PCV10 in Kenya and effectiveness of maternal antibodies on the hazard of acquisition of serotype specific carriage of pneumococcus. Poster, 10th International Symposium on Pneumococci and Pneumococcal Diseases, 26-30 June, Glasgow, Scotland

Adetifa I (2016) Using pneumococcal carriage data to predict post-vaccination changes to invasive disease in rural Kenya- a validation exercise using Kilifi data. And antimicrobial resistance of pneumococci before and after the PCV10 introduction in Kilifi, Kenya (1998-2014). Poster, 10th International Symposium on Pneumococci and Pneumococcal Diseases, 26-30 June, Glasgow, Scotland

Silaba M (2016) Validity and reliability of paediatric chest radiographic end-points used in the PCVIS in Kilifi, Kenya. Poster 10th International Symposium on Pneumococci and Pneumococcal Diseases, 26-30 June, Glasgow, Scotland

Podcasts

KWTRP (2017) Dr. Olive Akunga discusses the burden of pneumonia on child health, and research into a new whole cell vaccine as a cost-effective strategy to combatting pneumonia.

News

Gavi (2014) Protecting the herd from pneumococcal disease. Gavi newspage

Reports

Gavi (2013) Kenya – Big Data A research study on the impact of pneumococcal vaccine in Kenya shows data-mining electronic medical records is vital to transforming health care. Gavi report

Videos

Gavi (2015) The pneumococcal conjugate vaccine impact study explained: